From multimode to monomode guided atom lasers: an entropic analysis

We have experimentally demonstrated a high level of control of the mode populations of guided atom lasers (GALs) by showing that the entropy per particle of an optically GAL, and the one of the trapped Bose Einstein condensate (BEC) from which it has been produced are the same. The BEC is prepared in a crossed beam optical dipole trap. We have achieved isentropic outcoupling for both magnetic and optical schemes. We can prepare GAL in a nearly pure monomode regime (85 % in the ground state). Furthermore, optical outcoupling enables the production of spinor guided atom lasers and opens the possibility to tailor their polarization

Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature.

Borderline ovarian tumors (BOTs) account for 10-20% of epithelial ovarian neoplasms. They are characterized by their lack of destructive stromal invasion. In comparison to invasive ovarian cancers, BOTs occur in younger patients and have better outcome. Serous borderline ovarian tumor (SBOT) represents the most common subtype of BOT. Complete surgical staging is the current standard management but fertility-sparing surgery is an option for SBOT patients who are at reproductive age. While most cases of SBOTs have an indolent course with favorable prognosis, late recurrence and malignant transformation can occur, usually in the form of low-grade serous carcinoma (LGSC). Thus, assessment of the recurrence risk is essential for the management of those patients. SBOTs can be associated with lymph node involvement (LNI) in up to 30% of patients who undergo lymph node dissection at diagnosis, and whether LNI affects prognosis is controversial. The present review suggests that recurrent SBOTs with LNI have poorer oncological outcomes and highlights the biases due to the scarcity of reports in the literature. Preventing SBOTs from recurring and becoming invasive overtime and a more profound understanding of the underlying mechanisms at play are necessary

Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial.

Senticol 2 is a randomized multicenter trial in the treatment of early-stage cervical cancer patients. The aim of the Senticol 2 study was to compare the effect of sentinel-lymph-node biopsy (SLNB) to that of SLNB + pelvic lymphadenectomy (PLND), and to determine the postoperative lymphatic morbidity in the two groups. Here, we report a secondary objective of this study: the follow up. In the Senticol 2 trial, patients underwent a laparoscopy with a sentinel-node-detection procedure and were randomized into two groups, namely: Group A, in which participants received SLNB, and Group B, in which participants received SLNB + PLND. Patients with an intra-operative macroscopically suspicious lymph node, were given a frozen-section evaluation and were randomized only if the results were negative. All of the patients received follow up with a clinical examination at 1, 3, and 6 months after surgery, and then every 3-4 months after that. The median follow up was 51 months (4 years and 3 months). Disease-free survival after 4 years for the SLNB group and the SLNB + PLND group were 89.51% and 93.1% (p = 0.53), respectively. The only statistical factor associated with recurrence in the univariate analysis was the adjuvant radiotherapy. No other factors, including the age of the patients, histological type, tumor size, lymph vascular space invasion (LVSI), and positive nodal status, were significant in the univariate or multivariate analyses. The overall survival rates after 4 years in the SLNB and SLNB + PLND groups were 95.2% and 96% (p = 0.97), with five and four deaths, respectively. The univariate and multivariate analyses did not find any prognostic factors. This randomized study confirmed the results of the Senticol 1 study and supports the sentinel lymph node (SLN) technique as a safe technique for use in patients with early-stage cervical cancer treated with SLNB only. Disease-free survival after 4 years was similar in patients treated with SLN biopsy and patients who underwent a lymphadenectomy

Negative experimental evidence for magneto-orbital dichroism - supplemental information

A light beam can carry both spin angular momentum (SAM) and orbital angular momentum (OAM). SAM is commonly evidenced by circular dichroism (CD) experiments {\em i. e.} differential absorption of left and right-handed circularly polarized light. Recent experiments, supported by theoretical work, indicate that the corresponding effect with OAM instead of SAM is not observed in chiral matter. Isotropic materials can show CD when subjected to a magnetic field (MCD). In Ref. ~\onlinecite{Mathevet2012} we report a set of experiments, under well defined conditions, searching for magnetic orbital dichroism (MOD), differential absorption of light as a function of the sign of its OAM. We experimentally demonstrate that this effect, if any, is smaller than a few $10^{-4}$ of MCD for the Nd:YAG $^4I_{9/2}\rightarrow^4F_{5/2}$ transition. This transition is essentially of electric dipole nature. We give an intuitive argument suggesting that the lowest order of light matter interaction leading to MOD is the electric quadrupole term. We give here more experimental details and extra measurements.Comment: 6 pages, 7 figures. Supplemental material for a publication in Optics Expres

Zeeman slowers made simple with permanent magnets in a Halbach configuration

We describe a simple Zeeman slower design using permanent magnets. Contrary to common wire-wound setups no electric power and water cooling are required. In addition, the whole system can be assembled and disassembled at will. The magnetic field is however transverse to the atomic motion and an extra repumper laser is necessary. A Halbach configuration of the magnets produces a high quality magnetic field and no further adjustment is needed. After optimization of the laser parameters, the apparatus produces an intense beam of slow and cold 87Rb atoms. With a typical flux of 1 - 5 \times 10^10 atoms/s at 30 ms^-1, our apparatus efficiently loads a large magneto-optical trap with more than 10^10 atoms in one second, which is an ideal starting point for degenerate quantum gases experiments.Comment: 8+6 pages (article + appendices: calculation details, probe and oven description, pictures), 18 figures, supplementary material (movie, Mathematica programs and technical drawings

Cytological features of uterine tumors resembling ovarian sex-cord tumors in liquid-based cervical cytology: a potential pitfall. Report of a unique and rare case.

Uterine tumors resembling ovarian sex-cord tumors (UTROSCTs) are rare uterine neoplasms of uncertain etiology that resemble the sex cord tumors of the ovary and display a combined sex cord, epithelial, and smooth muscle immunophenotype. Most tumors are associated with a benign clinical course. We report the first cytological description of uterine UTROSCTs in liquid-based cervical cytology (LBC). A menopausal woman was discovered to have a uterine intraluminal polypoid mass protruding through the vagina. A Pap test was performed, and the LBC preparation showed isolated tumor cells with scant cytoplasm and slightly irregular, ovoid nuclei with fine chromatin and small nucleoli. Final histological evaluation identified a UTROSCT. This diagnostic possibility, albeit rare, should be included in the differential diagnosis when isolated malignant-appearing adenocarcinomatous cells are seen in women in the above scenario. As these features are not specific, they may result in misinterpretation with tumors that are more common and aggressive

Combination of image segmentation into regions

Segmentation is a preliminary stage before image interpretation . In this article we are interested in the problem of data fusion applied to image segmentation . The aim of the study is to combine different image segmentations to obtain a more reliable one. Data fusion is actually an interesting tool to obtain more reliable data from uncertain and anaccurate ones . We propose a segmentation combination method within the context of Dempster-Shafer theory . The basic probability assignment (bpa) are computed from the probability that a pixel belong to a region of its neighbourhood . The bpa are then combined with the Dempster rule of combination . The non-exhaustivity of the frame of discernement due to the under-segmentation is taken into account . The maximum of plausibility is used for decision-making . We present quantitative and comparative results concerning intensity images and depth images .La segmentation est une étape préalable à l'interprétation des images. Dans cet article, nous nous intéressons au problème de la fusion de données appliquée à la segmentation d'images. Le processus de segmentation doit extraire les informations «utiles d'une image numérique afin de reconnaître les entités présentes dans cette image. La fusion de données permet de pallier les lacunes de certaines modalités en mettant à profit la redondance et la complémentarité de l'ensemble des informations. Nous proposons une méthode de combinaison de segmentations décrites sous la forme de régions dans le cadre de la théorie de l'évidence. Les masses sont déduites des probabilités d'appartenance de chaque pixel de l'image aux régions de celles-ci. Ces masses sont combinées par la règle de combinaison de Dempster en gérant préalablement la non-exhaustivité du cadre de discernement due aux sous-segmentations d'une image par rapport à l'autre. La prise de décision est réalisée par le maximum de plausibilité. Des résultats quantitatifs et comparatifs viennent illustrer la méthode

Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2).

Pelvic lymph node dissection has been the standard of care for patients with early cervical cancer. Sentinel node (SN) mapping is safe and feasible and may increase the detection of metastatic disease, but benefits of omitting pelvic lymph node dissection in terms of decreased morbidity have not been demonstrated. In an open-label study, patients with early cervical carcinoma (FIGO 2009 stage IA2 to IIA1) were randomly assigned to SN resection alone (SN arm) or SN and pelvic lymph node dissection (SN + PLND arm). SN resection was followed by radical surgery of the tumour (radical hysterectomy or radical trachelectomy). The primary end-point was morbidity related to the lymph node dissection; 3-year recurrence-free survival was a secondary end-point. A total of 206 patients were eligible and randomly assigned to the SN arm (105 patients) or SN + PLND arm (101 patients). Most patients had stage IB1 lesion (87.4%). No false-negative case was observed in SN + PLND arm. Lymphatic morbidity was significantly lower in the SN arm (31.4%) than in the SN + PLND arm (51.5%; p = 0.0046), as was the rate of postoperative neurological symptoms (7.8% vs. 20.6%, p = 0.01, respectively). However, there was no significant difference in the proportion of patients with significant lymphoedema between the two groups. During the 6-month postoperative period, the difference in morbidity decreased over time. The 3-year recurrence-free survival was not significantly different (92.0% in SN arm and 94.4% in SN + PLND arm). SN resection alone is associated with early decreased lymphatic morbidity when compared with SN + PLND in early cervical cancer

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.

Most ovarian cancer patients are diagnosed at a late stage with 85% of them relapsing after surgery and standard chemotherapy; for this reason, new treatments are urgently needed. Ovarian cancer has become a candidate for immunotherapy by reason of their expression of shared tumor-associated antigens (TAAs) and private mutated neoantigens (NeoAgs) and the recognition of the tumor by the immune system. Additionally, the presence of intraepithelial tumor infiltrating lymphocytes (TILs) is associated with improved progression-free and overall survival of patients with ovarian cancer. The aim of active immunotherapy, including vaccination, is to generate a new anti-tumor response and amplify an existing immune response. Recently developed NeoAgs-based cancer vaccines have the advantage of being more tumor specific, reducing the potential for immunological tolerance, and inducing robust immunogenicity. We propose a randomized phase I/II study in patients with advanced ovarian cancer to compare the immunogenicity and to assess safety and feasibility of two personalized DC vaccines. After standard of care surgery and chemotherapy, patients will receive either a novel vaccine consisting of autologous DCs pulsed with up to ten peptides (PEP-DC), selected using an agnostic, yet personalized, epitope discovery algorithm, or a sequential combination of a DC vaccine loaded with autologous oxidized tumor lysate (OC-DC) prior to an equivalent PEP-DC vaccine. All vaccines will be administered in combination with low-dose cyclophosphamide. This study is the first attempt to compare the two approaches and to use NeoAgs-based vaccines in ovarian cancer in the adjuvant setting. The proposed treatment takes advantage of the beneficial effects of pre-treatment with OC-DC prior to PEP-DC vaccination, prompting immune response induction against a wide range of patient-specific antigens, and amplification of pre-existing NeoAgs-specific T cell clones. Trial registration This trial is already approved by Swissmedic (Ref.: 2019TpP1004) and will be registered at http://www.clinicaltrials.gov before enrollment opens